Naperville, IL, United States of America

Chandra K Mayanil

This inventor holds 1 USPTO granted patent. Top assignee: Prime Bio, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chandra K Mayanil. Retrieved from https://idiyas.com/inventor/chandra-k-mayanil

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chandra K Mayanil: Innovator in Cancer Treatment

Introduction

Chandra K Mayanil is a prominent inventor based in Naperville, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. Her innovative work focuses on developing compositions that can effectively combat various types of tumors.

Latest Patents

Chandra K Mayanil holds a patent for a pharmaceutical composition aimed at treating cancer. This composition includes ascorbic acid, caffeoylquinic acid, rosmarinic acid, and glycosyl sulfones. The claimed invention also outlines a process for isolating this composition. Additionally, it provides a method for treating neural crest-derived tumors, such as malignant neurofibroma and melanoma. She has 1 patent to her name.

Career Highlights

Chandra is currently associated with Prime Bio, Inc., where she continues her research and development efforts. Her work is pivotal in advancing cancer treatment options and improving patient outcomes.

Collaborations

Chandra collaborates with notable colleagues, including Bal Ram Singh and Tadanori Tomita. These partnerships enhance her research capabilities and contribute to the innovative environment at Prime Bio, Inc.

Conclusion

Chandra K Mayanil is a dedicated inventor whose work in pharmaceutical compositions is making strides in cancer treatment. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…